A detailed history of Ossiam transactions in United Therapeutics Corp stock. As of the latest transaction made, Ossiam holds 2,144 shares of UTHR stock, worth $666,869. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,144
Previous 5,225 58.97%
Holding current value
$666,869
Previous $1.15 Million 57.14%
% of portfolio
0.01%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$210.76 - $249.51 $649,351 - $768,740
-3,081 Reduced 58.97%
2,144 $492,000
Q4 2023

Feb 13, 2024

SELL
$214.88 - $256.94 $331,774 - $396,715
-1,544 Reduced 22.81%
5,225 $1.15 Million
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $1.18 Million - $1.38 Million
5,567 Added 463.14%
6,769 $1.53 Million
Q2 2023

Aug 11, 2023

BUY
$205.19 - $232.99 $148,967 - $169,150
726 Added 152.52%
1,202 $265,000
Q1 2023

May 12, 2023

BUY
$212.99 - $276.17 $2,768 - $3,590
13 Added 2.81%
476 $106,000
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $94,127 - $113,050
463 New
463 $97,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Ossiam Portfolio

Follow Ossiam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.